Application of cell growth analysis to the quality assessment of human cell-processed therapeutic products as a testing method for immortalized cellular impurities

Nozomi Hasebe-Takada, Ken Kono, Satoshi Yasuda, Rumi Sawada, Akifumi Matsuyama, Yoji Sato

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In human cell-processed therapeutic products (hCTPs) for clinical application, tumorigenic cellular impurities in the manufacturing process are a major concern. Because cellular immortalization is one of the prerequisite steps in tumorigenesis, we tested whether cell growth analysis can be employed to check for immortalized (and potentially tumorigenic) cellular impurities in hCTPs. We monitored the growth of human bone marrow-derived mesenchymal stem cells (BMSCs) mixed with HeLa cells at a ratio of 1/106 or more and compared their growth rates with that of BMSCs alone. The cell growth analysis detected a significant increase in the growth rate of the BMSCs spiked with 0.0001% HeLa within 30 days at a probability of 47%. When human adipose-derived stem cells (ADSCs) were spiked with ASC52telo cells, a human telomerase reverse transcriptase (hTERT)-immortalized adipose-derived mesenchymal stem cell line, at a ratio of 0.001% or more, their growth rates were significantly increased within 15 passages, compared with that of ADSCs alone. These results indicate that cell growth analysis for the detection of immortalized cellular impurities in human somatic stem cells is simple and can be useful for the quality assessment of hCTPs in the manufacturing process.

Original languageEnglish
Pages (from-to)49-54
Number of pages6
JournalRegenerative Therapy
Volume5
DOIs
Publication statusPublished - 01-12-2016

Fingerprint

Cell growth
Stem cells
Cells
Impurities
Mesenchymal Stromal Cells
Testing
Growth
Bone
Bone Marrow
Therapeutics
Stem Cells
Adult Stem Cells
HeLa Cells
Carcinogenesis
Cell Line

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering
  • Developmental Biology

Cite this

@article{ec214fd47f264df69e5e28ab075773b9,
title = "Application of cell growth analysis to the quality assessment of human cell-processed therapeutic products as a testing method for immortalized cellular impurities",
abstract = "In human cell-processed therapeutic products (hCTPs) for clinical application, tumorigenic cellular impurities in the manufacturing process are a major concern. Because cellular immortalization is one of the prerequisite steps in tumorigenesis, we tested whether cell growth analysis can be employed to check for immortalized (and potentially tumorigenic) cellular impurities in hCTPs. We monitored the growth of human bone marrow-derived mesenchymal stem cells (BMSCs) mixed with HeLa cells at a ratio of 1/106 or more and compared their growth rates with that of BMSCs alone. The cell growth analysis detected a significant increase in the growth rate of the BMSCs spiked with 0.0001{\%} HeLa within 30 days at a probability of 47{\%}. When human adipose-derived stem cells (ADSCs) were spiked with ASC52telo cells, a human telomerase reverse transcriptase (hTERT)-immortalized adipose-derived mesenchymal stem cell line, at a ratio of 0.001{\%} or more, their growth rates were significantly increased within 15 passages, compared with that of ADSCs alone. These results indicate that cell growth analysis for the detection of immortalized cellular impurities in human somatic stem cells is simple and can be useful for the quality assessment of hCTPs in the manufacturing process.",
author = "Nozomi Hasebe-Takada and Ken Kono and Satoshi Yasuda and Rumi Sawada and Akifumi Matsuyama and Yoji Sato",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.reth.2016.06.005",
language = "English",
volume = "5",
pages = "49--54",
journal = "Regenerative Therapy",
issn = "2352-3204",
publisher = "Japanese Society of Regenerative Medicine",

}

Application of cell growth analysis to the quality assessment of human cell-processed therapeutic products as a testing method for immortalized cellular impurities. / Hasebe-Takada, Nozomi; Kono, Ken; Yasuda, Satoshi; Sawada, Rumi; Matsuyama, Akifumi; Sato, Yoji.

In: Regenerative Therapy, Vol. 5, 01.12.2016, p. 49-54.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Application of cell growth analysis to the quality assessment of human cell-processed therapeutic products as a testing method for immortalized cellular impurities

AU - Hasebe-Takada, Nozomi

AU - Kono, Ken

AU - Yasuda, Satoshi

AU - Sawada, Rumi

AU - Matsuyama, Akifumi

AU - Sato, Yoji

PY - 2016/12/1

Y1 - 2016/12/1

N2 - In human cell-processed therapeutic products (hCTPs) for clinical application, tumorigenic cellular impurities in the manufacturing process are a major concern. Because cellular immortalization is one of the prerequisite steps in tumorigenesis, we tested whether cell growth analysis can be employed to check for immortalized (and potentially tumorigenic) cellular impurities in hCTPs. We monitored the growth of human bone marrow-derived mesenchymal stem cells (BMSCs) mixed with HeLa cells at a ratio of 1/106 or more and compared their growth rates with that of BMSCs alone. The cell growth analysis detected a significant increase in the growth rate of the BMSCs spiked with 0.0001% HeLa within 30 days at a probability of 47%. When human adipose-derived stem cells (ADSCs) were spiked with ASC52telo cells, a human telomerase reverse transcriptase (hTERT)-immortalized adipose-derived mesenchymal stem cell line, at a ratio of 0.001% or more, their growth rates were significantly increased within 15 passages, compared with that of ADSCs alone. These results indicate that cell growth analysis for the detection of immortalized cellular impurities in human somatic stem cells is simple and can be useful for the quality assessment of hCTPs in the manufacturing process.

AB - In human cell-processed therapeutic products (hCTPs) for clinical application, tumorigenic cellular impurities in the manufacturing process are a major concern. Because cellular immortalization is one of the prerequisite steps in tumorigenesis, we tested whether cell growth analysis can be employed to check for immortalized (and potentially tumorigenic) cellular impurities in hCTPs. We monitored the growth of human bone marrow-derived mesenchymal stem cells (BMSCs) mixed with HeLa cells at a ratio of 1/106 or more and compared their growth rates with that of BMSCs alone. The cell growth analysis detected a significant increase in the growth rate of the BMSCs spiked with 0.0001% HeLa within 30 days at a probability of 47%. When human adipose-derived stem cells (ADSCs) were spiked with ASC52telo cells, a human telomerase reverse transcriptase (hTERT)-immortalized adipose-derived mesenchymal stem cell line, at a ratio of 0.001% or more, their growth rates were significantly increased within 15 passages, compared with that of ADSCs alone. These results indicate that cell growth analysis for the detection of immortalized cellular impurities in human somatic stem cells is simple and can be useful for the quality assessment of hCTPs in the manufacturing process.

UR - http://www.scopus.com/inward/record.url?scp=85041062500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041062500&partnerID=8YFLogxK

U2 - 10.1016/j.reth.2016.06.005

DO - 10.1016/j.reth.2016.06.005

M3 - Article

AN - SCOPUS:85041062500

VL - 5

SP - 49

EP - 54

JO - Regenerative Therapy

JF - Regenerative Therapy

SN - 2352-3204

ER -